Why we should understand the patient experience: clinical empathy and medicines optimisation

E-ISSN： 2042-7174|24|5|367-370

ISSN： 0961-7671

Source： International Journal Of Pharmacy Practice, Vol.24, Iss.5, 2016-10, pp. : 367-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 7, 2007-07 ,pp. : 693-699

Bentham Science Publishers

Access to resources Recommend Favorite

Real-life Experience of Clinical Efficacy of Omalizumab Use in the MiddleEast: Should We Also Be Concerned About Parasites?

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 43-46

Bentham Science Publishers

Access to resources Recommend Favorite

Professional attitudes: why we should care

By Martin Jonathan Dacre Jane

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 182-184

Royal College Of Physicians

Access to resources Recommend Favorite

How can we (and why should we) develop better models of recovery?

By Leighton Tim

Addiction Research and Theory, Vol. 15, Iss. 5, 2007-07 ,pp. : 435-438

Informa Healthcare

Access to resources Recommend Favorite

Methotrexate: Should We Start Using it in Clinical Practice?

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1480-1489

Bentham Science Publishers

Access to resources Recommend Favorite